Martin Lauss
Lund University(SE)Medicon Village(SE)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Melanoma and MAPK Pathways, RNA modifications and cancer, Immunotherapy and Immune Responses, Cancer Genomics and Diagnostics
Most-Cited Works
- → Tertiary lymphoid structures improve immunotherapy and survival in melanoma(2020)2,253 cited
- → A Molecular Taxonomy for Urothelial Carcinoma(2012)986 cited
- → Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma(2017)486 cited
- → Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma(2012)227 cited
- → Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy(2015)191 cited
- → Toward a Molecular Pathologic Classification of Urothelial Carcinoma(2013)175 cited
- → NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics(2017)132 cited
- → A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma(2015)131 cited
- → Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors(2014)127 cited
- → B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?(2021)123 cited